The use of chemotherapeutics for the treatment of keloid scars

被引:46
作者
Jones, Christopher David [1 ]
Guiot, Luke [2 ]
Samy, Mike [3 ]
Gorman, Mark [1 ]
Tehrani, Hamid [4 ]
机构
[1] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
[2] Univ Hosp Ayr, Ankara, Turkey
[3] St Bartholomews & London Sch Med & Dent, London, England
[4] Whiston Hosp, Prescot, Merseyside, England
关键词
Keloid; hypertrophic scar; chemotherapeutic agents;
D O I
10.4081/dr.2015.5880
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Keloid scars are pathological scars, which develop as a result of exaggerated dermal tissue proliferation following cutaneous injury and often cause physical, psychological and cosmetic problems. Various theories regarding keloidogenesis exist, however the precise pathophysiological events remain unclear. Many different treatment modalities have been implicated in their management, but currently there is no entirely satisfactory method for treating all keloid lesions. We review a number of different chemotherapeutic agents which have been proposed for the treatment of keloid and hypertrophic scars while giving insight into some of the novel chemotherapeutic drugs which are currently being investigated. Non-randomized trials evaluating the influence of different chemotherapeutic agents, such as 5-fluorouracil (5-FU); mitomycin C; bleomycin and steroid injection, either alone or in combination with other chemotherapeutic agents or alternative treatment modalities, for the treatment of keloids were identified using a predefined PubMed search strategy. Twenty seven papers were identified. Scar improvement >= 50% was found in the majority of cases treated with 5-FU, with similar results found for mitomycin C, bleomycin and steroid injection. Combined intralesional 5-FU and steroid injection produced statistically significant improvements when compared to monotherapy. Monotherapy recurrence rates ranged from 0-47% for 5-FU, 0-15% for bleomycin and 0-50% for steroid injection. However, combined therapy in the form of surgical excision and adjuvant 5-FU or steroid injections demonstrated lower recurrence rates; 19% and 6% respectively. Currently, most of the literature supports the use of combination therapy (usually surgery and adjuvant chemotherapy) as the mainstay treatment of keloids, however further investigation is necessary to determine success rates over longer time frames. Furthermore, there is the potential for novel therapies, but further investigation is required to elucidate their true efficacy.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 49 条
[1]  
Apikian Martine, 2004, Australas J Dermatol, V45, P140, DOI 10.1111/j.1440-0960.2004.00072.x
[2]   Treatment of a Postburn Keloid Scar with Topical Captopril: Report of the First Case [J].
Ardekani, Gholamreza Safaee ;
Aghaie, Shahin ;
Nemati, Mohammad Hassan ;
Handjani, Farhad ;
Kasraee, Behrooz .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2009, 123 (03) :112E-113E
[3]   New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars [J].
Asilian, Ali ;
Darougheh, Afshin ;
Shariati, Fazlolah .
DERMATOLOGIC SURGERY, 2006, 32 (07) :907-915
[4]   Imiquimod 5% cream for keloid management [J].
Berman, B ;
Villa, A .
DERMATOLOGIC SURGERY, 2003, 29 (10) :1050-1051
[5]   Failure of Imiquimod 5% Cream to Prevent Recurrence of Surgically Excised Trunk Keloids [J].
Cacao, Fernanda Marson ;
Tanaka, Vanessa ;
de Lourenzo Messina, Maria Cristina .
DERMATOLOGIC SURGERY, 2009, 35 (04) :629-633
[6]   Tamoxifen downregulates TGF-β production in keloid fibroblasts [J].
Chau, D ;
Mancoll, JS ;
Lee, S ;
Zhao, JG ;
Phillips, LG ;
Gittes, GK ;
Longaker, MT .
ANNALS OF PLASTIC SURGERY, 1998, 40 (05) :490-493
[7]  
Cheng E T, 2001, Arch Facial Plast Surg, V3, P252, DOI 10.1001/archfaci.3.4.252
[8]   Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars [J].
Darougheh, A. ;
Asilian, A. ;
Shariati, F. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (02) :219-223
[9]   TISSUE ALPHA-GLOBULINS IN KELOID FORMATION [J].
DIEGELMANN, RF ;
BRYANT, CP ;
COHEN, IK .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1977, 59 (03) :418-423
[10]  
Dinh Quan, 2004, Australas J Dermatol, V45, P162, DOI 10.1111/j.1440-0960.2004.00079.x